Elanco Animal Health
Price chart
Anonymous reader poll. Unscientific, not investment advice.
✦ StockVane Quant Insights how this is computed
- Mid-pack momentum — held if you own it, not a fresh buy.
- Signal has read HOLD for 1 week.
- Recent price momentum is +15.2% on average (3-month/1-year).
- Main-fund capital flow has been a net outflow over the last 45 sessions.
- Short interest has risen to 6.6% of float.
- Analyst tilt is Buy.
- Price is above its 20-day average and above its 60-day average.
- The 20-day average is above the 60-day average, a short-term uptrend.
Computed by a StockVane algorithm from historical price, valuation and analyst data - not a person, not a forecast guarantee, and not investment advice.
Factor grades
Ranked against 2848 U.S. stocks StockVane covers.
Last computed: 2026-11-21 20:27 UTC
Data coverage: 6 of 6 factors. Missing data is not a zero score.
Valuation D
How expensive the stock is versus earnings, sales and its own 5-year history.
| Forward P/E | 256.8x | Better than 1% |
| Price / Sales | 2.6x | Better than 48% |
Growth C
How fast revenue, profit and free cash flow are compounding.
| Revenue CAGR (3Y) | 2.2% | Better than 36% |
| Free cash flow CAGR (3Y) | 2.0% | Better than 41% |
Profitability C
How much profit the business keeps from each dollar of sales and capital.
| Gross margin | 55.0% | Better than 69% |
| Operating margin | 5.3% | Better than 36% |
| Net margin | -4.9% | Better than 19% |
| Return on equity | -3.7% | Better than 24% |
| Return on invested capital | -0.7% | Better than 27% |
Momentum A-
Recent price strength, skipping the latest month to avoid short-term noise.
| 3-month return | 7.4% | Better than 87% |
| 6-month return | 18.5% | Better than 81% |
| 12-month return (ex latest month) | 2.0% | Better than 35% |
| Distance below 52-week high | 8.0% | Better than 88% |
Financial Health C
Balance-sheet strength: leverage, liquidity and interest coverage.
| Current ratio | 2.2x | Better than 60% |
| Debt to assets | 30.1% | Better than 41% |
| Interest coverage | 0.0x | Better than 24% |
| Free cash flow / net income | 112.4% | Better than 47% |
Analyst View B-
What the Street thinks: share of Buy ratings and upside to the average target.
| Analysts rating Buy | 81.8% | Better than 62% |
| Upside to average target | 20.1% | Better than 33% |
Grades are relative rankings, not forecasts: A+ is the top 5% of the covered stocks on a factor, F the bottom 3%. Valuation is not adjusted for sector. Background recomputation is scheduled every 6 hours; actual computation time is shown above, and source datasets have different reporting dates. Not investment advice or tailored to your financial situation.
Performance
Key statistics
Price & volume
- Prev close
- 26.29
- Open
- 26.22
- Day range
- 25.58 - 26.93
- Avg price
- 25.87
- Volume
- 5.83M
- Turnover
- 150.90M
- Turnover ratei
- 1.18%
- Volume ratioi
- 1.12
- Amplitudei
- 5.15%
- 52-week rangei
- 19.40 - 27.98
Valuation
- P/Ei
- -54.77
- P/E (TTM)i
- -85.80
- P/Bi
- 1.94
- EPSi
- -0.47
- Book value / shi
- 13.26
- Net profit
- -234.92M
- Net assets
- 6.63B
Share structure
- Market cap
- 12.87B
- Float capi
- 12.76B
- Shares out
- 499.83M
- Float sharesi
- 495.70M
Dividend & listing
- Div yield (TTM)i
- 0.00%
- Dividend (TTM)
- 0.00
- Listing date
- 2018-09-21
8.0% below the 52-week high
Trading activity
Net capital flow main funds, last 45 sessions
-2.71M net over the window
Short interest
- Shares short
- 32.92M
- % of floati
- 6.59%
- Days to coveri
- 7.18
- As of
- 2026-10-30
Frequently asked questions
What is the current stock price of Elanco Animal Health (ELAN)?
Elanco Animal Health last traded at 25.74. This page shows a periodic quote snapshot. Check the displayed quote time.
What is Elanco Animal Health's market cap?
About 12.87B.
What is the P/E ratio of Elanco Animal Health?
The trailing twelve-month P/E is -85.80. The Valuation tab shows it against the stock's own five-year range.
Does Elanco Animal Health pay a dividend?
Elanco Animal Health does not currently pay a regular dividend.
Is Elanco Animal Health a buy according to analysts?
The consensus of 11 analysts is a Buy rating, with an average 12-month price target of 30.91, which implies 20.1% upside from the current price. This is not investment advice.
What is Elanco Animal Health's StockVane Quant Rating?
The StockVane Momentum strategy currently rates Elanco Animal Health a C (Hold). Mid-pack momentum — held if you own it, not a fresh buy. Not investment advice.
Quote time 2026-11-20 20:02:31 · For reference only, not investment advice and not tailored to your situation.
Elanco Animal Health discussion 0 comments